Surgery Partners, Inc. (SGRY) stock
SGRYNasdaqServices-General Medical & Surgical Hospitals, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 5/3011% above fair value
$26.85+0.06 (+0.22%)
Close on Nov 17, 2026Market cap $3.52BP/E –Yield –
Surgery Partners operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Surgery Partners's operating cash flow for the twelve months ending Jun 30, 2026 was $258.00M, down 2.2% year over year. For fiscal 2025 it was $274.30M, down 8.6% from the year before. Over ten years it grew 28.7% a year on average. The highest annual figure on record is $300.10M in fiscal 2024.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $274.30M | -8.6% |
| FY2024 | Dec 31, 2024 | $300.10M | +2.1% |
| FY2023 | Dec 31, 2023 | $293.80M | +85.0% |
| FY2022 | Dec 31, 2022 | $158.80M | +82.3% |
| FY2021 | Dec 31, 2021 | $87.10M | -64.7% |
| FY2020 | Dec 31, 2020 | $246.90M | +90.7% |
| FY2019 | Dec 31, 2019 | $129.50M | -10.4% |
| FY2018 | Dec 31, 2018 | $144.60M | +15.5% |
| FY2016 | Dec 31, 2016 | $125.24M | +48.2% |
| FY2015 | Dec 31, 2015 | $84.48M | +284.9% |
| FY2014 | Dec 31, 2014 | $21.95M | -55.3% |
| FY2013 | Dec 31, 2013 | $49.08M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $59.30M | -27.1% |
| Q1 FY2026 | Mar 31, 2026 | $11.70M | +95.0% |
| Q4 FY2025 | Dec 31, 2025 | $103.40M | -7.2% |
| Q3 FY2025 | Sep 30, 2025 | $83.60M | +28.2% |
| Q2 FY2025 | Jun 30, 2025 | $81.30M | -1.8% |
| Q1 FY2025 | Mar 31, 2025 | $6.00M | -85.3% |
| Q4 FY2024 | Dec 31, 2024 | $111.40M | +78.0% |
| Q3 FY2024 | Sep 30, 2024 | $65.20M | -37.7% |
| Q2 FY2024 | Jun 30, 2024 | $82.80M | +58.9% |
| Q1 FY2024 | Mar 31, 2024 | $40.70M | -45.4% |
| Q4 FY2023 | Dec 31, 2023 | $62.60M | +769.4% |
| Q3 FY2023 | Sep 30, 2023 | $104.60M | +252.2% |
| Q2 FY2023 | Jun 30, 2023 | $52.10M | +23.8% |
| Q1 FY2023 | Mar 31, 2023 | $74.50M | -6.6% |
| Q4 FY2022 | Dec 31, 2022 | $7.20M | -63.5% |
| Q3 FY2022 | Sep 30, 2022 | $29.70M | +99.3% |
| Q2 FY2022 | Jun 30, 2022 | $42.10M | +1730.4% |
| Q1 FY2022 | Mar 31, 2022 | $79.80M | +59.0% |
| Q4 FY2021 | Dec 31, 2021 | $19.70M | +121.3% |
| Q3 FY2021 | Sep 30, 2021 | $14.90M | -44.6% |
| Q2 FY2021 | Jun 30, 2021 | $2.30M | -98.7% |
| Q1 FY2021 | Mar 31, 2021 | $50.20M | +71.9% |
| Q4 FY2020 | Dec 31, 2020 | $8.90M | -65.0% |
| Q3 FY2020 | Sep 30, 2020 | $26.90M | -52.7% |
| Q2 FY2020 | Jun 30, 2020 | $181.90M | +581.3% |
| Q1 FY2020 | Mar 31, 2020 | $29.20M | +42.4% |
| Q4 FY2019 | Dec 31, 2019 | $25.40M | -44.2% |
| Q3 FY2019 | Sep 30, 2019 | $56.90M | +92.9% |
| Q2 FY2019 | Jun 30, 2019 | $26.70M | -32.6% |
| Q1 FY2019 | Mar 31, 2019 | $20.50M | -31.7% |
| Q4 FY2018 | Dec 31, 2018 | $45.50M | +110.6% |
| Q3 FY2018 | Sep 30, 2018 | $29.50M | -15.4% |
| Q2 FY2018 | Jun 30, 2018 | $39.60M | +22.3% |
| Q1 FY2018 | Mar 31, 2018 | $30.00M | +59.4% |
| Q2 FY2017 | Jun 30, 2017 | $21.60M | – |
| Q1 FY2017 | Mar 31, 2017 | $34.87M | – |
| Q4 FY2016 | Dec 31, 2016 | $32.38M | – |
| Q3 FY2016 | Sep 30, 2016 | $18.83M | – |
See a number that looks wrong?